Tuhin Sajjad SK

Tuhin is an independent science journalist from West Bengal. He always blends scientific accuracy with creative storytelling. He focuses on promoting scientific temperament and contributes to SDG-3 and SDG-13 through his work. He has also spoken at the Science Journalism Forum 2025 and holds a verified NASA Open Science Skills certificate.

Exclusive Content

spot_img

From the Moon to the Manhole: Can India’s Tech Revolution Finally Dignify Its Sewers?

India has sent missions to the Moon, yet sanitation workers still risk their lives inside sewers. At Durgapur, CSIR-CMERI is developing mechanised cleaning technology that could replace dangerous human entry, prevent deaths and help end the generational stigma attached to manual scavenging.

Alien Spacecraft Rumours Around 3I/ATLAS End as Bengali Scientists Confirm It Is a Natural Interstellar Comet

Bengali scientists using India’s uGMRT radio telescope confirm interstellar object 3I/ATLAS is a natural comet, ending alien spacecraft rumours and opening new possibilities for studying extrasolar visitors.

Taking Science to Society: Inside ISNA and Radio Kolkata’s Unique Collaboration

The Indian Science News Association and Radio Kolkata have launched a joint science communication initiative to counter fake news, promote scientific temper, and revive interest in basic sciences. Using community radio and Indian languages, the collaboration aims to connect scientists, students, and society amid climate crisis and growing misinformation.

Indian Team Discovers 53 Giant Radio Quasars, Some 50 Times Bigger Than the Milky Way

Four Indian astronomers from West Bengal have discovered 53 giant radio quasars, each with jets millions of light-years long. Using TGSS data, the team identified rare, massive structures that reveal how black holes grow, how jets evolve, and how the early universe shaped asymmetric cosmic environments.

India’s Smallest Fighters, World’s Costliest Drug: Babies Battling a Rare Disease

Asmika, a 12-month-old baby from West Bengal, suffers from Spinal Muscular Atrophy Type-1, a rare and severe genetic disorder requiring the world’s most expensive drug, Zolgensma, priced at $2.1 million. Despite India’s National Policy for Rare Diseases, gaps in funding, accessibility, and coordination leave families like Asmika’s with limited options, relying heavily on arduous crowdfunding efforts. Experts call for a more empathetic government approach, strategic use of CSR funds, and stronger public-private partnerships to address the needs of rare disease patients in India

Not the Next Pandemic: Experts Demystify the Human Metapneumovirus Scare

First identified in 2001, hMPV traces its roots back to the late 19th century, diverging from avian strains. It spreads through close contact and respiratory droplets, causing cough, fever, and shortness of breath, with complications in severe cases. Experts highlight its similarity to other seasonal viruses like RSV and influenza, debunking fears of a new pandemic